Acumen Pharmaceuticals (ABOS) Interest Expenses (2021 - 2026)

Acumen Pharmaceuticals' Interest Expenses history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 4.5% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.3 million (up 4.38% YoY), while the FY2025 annual figure was $4.2 million, up 3.83% from the prior year.
• Interest Expenses came in at $1.1 million for Q1 2026 at Acumen Pharmaceuticals, down from $1.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.1 million in Q4 2025 to a low of $581000.0 in Q4 2023.
• A 4-year average of $994200.0 and a median of $1.0 million in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 78.49% in 2024 and advanced 2.3% in 2025, its largest moves.
• Acumen Pharmaceuticals' Interest Expenses stood at $581000.0 in 2023, then soared by 78.49% to $1.0 million in 2024, then advanced by 4.82% to $1.1 million in 2025, then declined by 1.66% to $1.1 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $1.1 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison